About Index Trending news
Analyze
Top 50 Pricing
Xeris Pharmaceuticals

Xeris Pharmaceuticals

Work at Xeris Pharmaceuticals? Add yourself to this profile

Xeris Pharmaceuticals

Xeris Pharmaceuticals is a specialty company developing patient-friendlyinjectables for indications in diabetes, epilepsy, and immunology.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series C)
$41,000,000
Redmile Group, Deerfield, Deerfield Partners, +3
Venture capital (Series C)
$41,000,000
Redmile Group, Deerfield Management Company, Sabby Management, +1
Employees

Team size

2
Locations
HQ
$41,000,000 Venture capital (Series C)
Xconomy

Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round

Health Funding
$41,000,000 Venture capital (Series C)
FinSMEs

Xeris Pharmaceuticals Closes $41M Series C Financing

Funding Health